Gene · 2633
Papers1,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis. | Cancer Med | 2023 | 36708070 | PubTator, text mining | PubMed |
| Identification of the prognostic value of Th1/Th2 ratio and a novel prognostic signature in basal-like breast cancer. | Hereditas | 2023 | 36694223 | PubTator, text mining | PubMed |
| Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections. | J Immunother Cancer | 2023 | 36693678 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD‑L1 expression via STAT1 signaling. | Oncol Rep | 2023 | 36660930 | PubTator, text mining | PubMed |
| Rejection markers in kidney transplantation: do new technologies help children? | Pediatr Nephrol | 2023 | 36648536 | PubTator, text mining | PubMed |
| Sex and prior exposure jointly shape innate immune responses to a live herpesvirus vaccine. | Elife | 2023 | 36648132 | PubTator, text mining | PubMed |
| Domain motions, dimerization, and membrane interactions of the murine guanylate binding protein 2. | Sci Rep | 2023 | 36639389 | PubTator, text mining | PubMed |
| Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy. | Cancer Cell | 2023 | 36638784 | PubTator, text mining | PubMed |
| Intersectional vulnerability in the relationship between discrimination and inflammatory gene expression. | Brain Behav Immun Health | 2023 | 36632340 | PubTator, text mining | PubMed |
| Guanylate-binding protein 1 restricts avian coronavirus infectious bronchitis virus-infected HD11 cells. | Poult Sci | 2023 | 36580763 | PubTator, text mining | PubMed |
| Relating Molecular T Cell-mediated Rejection Activity in Kidney Transplant Biopsies to Time and to Histologic Tubulitis and Atrophy-fibrosis. | Transplantation | 2023 | 36575574 | PubTator, text mining | PubMed |
| TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | J Cell Biol | 2023 | 36574265 | PubTator, text mining | PubMed |
| Circ_0058608 contributes to the progression and taxol resistance of non-small cell lung cancer by sponging miR-1299 to upregulate GBP1. | Anticancer Drugs | 2023 | 36539364 | PubTator, text mining | PubMed |
| Identifying the key genes of Epstein-Barr virus-regulated tumour immune microenvironment of gastric carcinomas. | Cell Prolif | 2023 | 36519208 | PubTator, text mining | PubMed |
| IFIH1/IRF1/STAT1 promotes sepsis associated inflammatory lung injury via activating macrophage M1 polarization. | Int Immunopharmacol | 2023 | 36462334 | PubTator, text mining | PubMed |
| Differential expression of interferon inducible protein: Guanylate binding protein (GBP1 & GBP2) in severe dengue. | Free Radic Biol Med | 2023 | 36460216 | PubTator, text mining | PubMed |
| Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease. | J Clin Invest | 2023 | 36445779 | PubTator, text mining | PubMed |
| N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy. | Gastroenterology | 2023 | 36402190 | PubTator, text mining | PubMed |
| Transcriptional expression of CXCL10 and STAT1 in lupus nephritis and the intervention effect of triptolide. | Clin Rheumatol | 2023 | 36374433 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2633/papers?page=18